These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29165639)

  • 61. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
    Creighton CJ; Hernandez-Herrera A; Jacobsen A; Levine DA; Mankoo P; Schultz N; Du Y; Zhang Y; Larsson E; Sheridan R; Xiao W; Spellman PT; Getz G; Wheeler DA; Perou CM; Gibbs RA; Sander C; Hayes DN; Gunaratne PH;
    PLoS One; 2012; 7(3):e34546. PubMed ID: 22479643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accurate detection for a wide range of mutation and editing sites of microRNAs from small RNA high-throughput sequencing profiles.
    Zheng Y; Ji B; Song R; Wang S; Li T; Zhang X; Chen K; Li T; Li J
    Nucleic Acids Res; 2016 Aug; 44(14):e123. PubMed ID: 27229138
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
    Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
    Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
    Han L; Diao L; Yu S; Xu X; Li J; Zhang R; Yang Y; Werner HMJ; Eterovic AK; Yuan Y; Li J; Nair N; Minelli R; Tsang YH; Cheung LWT; Jeong KJ; Roszik J; Ju Z; Woodman SE; Lu Y; Scott KL; Li JB; Mills GB; Liang H
    Cancer Cell; 2015 Oct; 28(4):515-528. PubMed ID: 26439496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer.
    Distefano R; Tomasello L; Rampioni Vinciguerra GL; Gasparini P; Xiang Y; Bagnoli M; Marceca GP; Fadda P; Laganà A; Acunzo M; Ma Q; Nigita G; Croce CM
    Cancer Res; 2022 Oct; 82(20):3687-3700. PubMed ID: 36040379
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adenosine-to-inosine RNA editing meets cancer.
    Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
    Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.
    Kawahara Y; Zinshteyn B; Chendrimada TP; Shiekhattar R; Nishikura K
    EMBO Rep; 2007 Aug; 8(8):763-9. PubMed ID: 17599088
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Using deep sequencing data for identification of editing sites in mature miRNAs.
    Alon S; Eisenberg E
    Methods Mol Biol; 2015; 1269():231-42. PubMed ID: 25577382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MicroRNAs and anticancer drugs.
    Xing Z; Li D; Yang L; Xi Y; Su X
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):233-9. PubMed ID: 24492536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A-to-I editing of microRNAs: regulating the regulators?
    Gommans WM
    Semin Cell Dev Biol; 2012 May; 23(3):251-7. PubMed ID: 22001383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.
    Mullany LE; Wolff RK; Herrick JS; Buas MF; Slattery ML
    PLoS One; 2015; 10(12):e0143894. PubMed ID: 26630397
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single-nucleotide polymorphisms among microRNA: big effects on cancer.
    Song FJ; Chen KX
    Chin J Cancer; 2011 Jun; 30(6):381-91. PubMed ID: 21627860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
    Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
    Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
    [TBL] [Abstract][Full Text] [Related]  

  • 74. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Understanding the CREB1-miRNA feedback loop in human malignancies.
    Wang YW; Chen X; Ma R; Gao P
    Tumour Biol; 2016 Jul; 37(7):8487-502. PubMed ID: 27059735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells.
    Seo HA; Hwang CY; Moeng S; Park JK
    J Vis Exp; 2019 May; (147):. PubMed ID: 31180351
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identifying miRNAs, targets and functions.
    Liu B; Li J; Cairns MJ
    Brief Bioinform; 2014 Jan; 15(1):1-19. PubMed ID: 23175680
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell-type-specific signatures of microRNAs on target mRNA expression.
    Sood P; Krek A; Zavolan M; Macino G; Rajewsky N
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2746-51. PubMed ID: 16477010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A catalog of polymorphisms falling in microRNA-binding regions of cancer genes.
    Landi D; Gemignani F; Barale R; Landi S
    DNA Cell Biol; 2008 Jan; 27(1):35-43. PubMed ID: 17941804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.